BAKER Bros. Advisors L.P., Director, 10% Owner at GENOMIC HEALTH INC (GHDX), sold 255,970 shares at $68.90 ($17.4M) on 2019-04-03, disclosed to the SEC on 2019-04-05.
Open-market sale of $17.4M GHDX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $68.90 | 93 | $6K | 0.0% |
| 2 | $68.90 | 1,230 | $85K | 0.5% |
| 3 | $68.90 | 1,374 | $95K | 0.5% |
| 4 | $68.90 | 2,121 | $146K | 0.8% |
| 5 | $68.90 | 12,305 | $848K | 4.9% |
| 6 | $68.90 | 80,146 |
| $5.5M |
| 31.7% |
| 7 | $66.64 | 78 | $5K | 0.0% |
| 8 | $66.64 | 1,025 | $68K | 0.4% |
| 9 | $66.64 | 1,145 | $76K | 0.4% |
| 10 | $66.64 | 1,768 | $118K | 0.7% |
| 11 | $66.64 | 10,253 | $683K | 3.9% |
| 12 | $66.64 | 66,784 | $4.5M | 25.5% |
| 13 | $68.63 | 25 | $2K | 0.0% |
| 14 | $68.63 | 324 | $22K | 0.1% |
| 15 | $68.63 | 362 | $25K | 0.1% |
| 16 | $68.63 | 559 | $38K | 0.2% |
| 17 | $68.63 | 3,242 | $222K | 1.3% |
| 18 | $68.63 | 21,116 | $1.4M | 8.3% |
| 19 | $68.72 | 734 | $50K | 0.3% |
| 20 | $68.72 | 50 | $3K | 0.0% |
| 21 | $68.72 | 1,134 | $78K | 0.4% |
| 22 | $68.72 | 42,863 | $2.9M | 16.9% |
| 23 | $68.72 | 6,581 | $452K | 2.6% |
| 24 | $68.72 | 658 | $45K | 0.3% |
| Total | $68.12 avg | 255,970 | $17.4M | 100% |
| Filing → |
| IGMS | BUY | 2024-03-28 | $6.8M | — | Filing → |
| MDGL | BUY | 2023-12-14 | $45.0M | — | Filing → |
| TRDA | BUY | 2022-05-24 | $396K | — | Filing → |